This bill appropriates $35.6 million to Idaho's Department of Health and Welfare for public health services in fiscal year 2027, while simultaneously reducing funding for laboratory services and health care policy initiatives. It also decreases the number of authorized full-time equivalent positions by three and mandates several reports on program outcomes, vaccine utilization, and immigration status for HIV prevention services. Although the bill was signed by the President, the Governor exercised a line-item veto on the section reducing funds for the Health Care Policy Initiatives Program.
This bill requires legislative approval for the Idaho Department of Health and Welfare to adjust Medicaid payment rates for Federally Qualified Health Centers and Rural Health Clinics when their scope of services changes. It establishes a process where clinics must notify the department 60 days before implementing service changes and submit a rate adjustment application after six months of full implementation, requiring a minimum 4.5% cost increase to qualify. The legislation sets specific timelines for department review and allows clinics to appeal final rate decisions, while also repealing certain existing administrative rules effective October 1, 2026.
This bill expands Medicaid eligibility in Idaho to include adults under 65 with incomes at or below 133% of the federal poverty level who currently lack other coverage. It requires the state to submit necessary plan amendments to the federal government within 90 days and ensures eligibility is not delayed while waiting for federal approval. The legislation includes provisions to maintain federal funding levels and requires a review of the program if federal support decreases, while also mandating community engagement requirements by December 2026 before enrollment becomes effective.
This bill appropriates state and federal funds to the Idaho Department of Health and Welfare and the State Independent Living Council for fiscal year 2027, covering programs like Medicaid, child welfare, mental health services, and substance abuse treatment. It establishes specific funding amounts for various divisions including youth safety, early learning, family partnerships, and benefit payments, while also limiting the number of authorized full-time equivalent positions. The legislation includes requirements for program integrity, monthly Medicaid tracking reports, and cost-sharing for certain services, and directs how specific funds must be used for initiatives like smoking cessation, opioid response, and rural physician incentives.
This bill allocates $200,000 from the state's General Fund to the Idaho Legislature for fiscal year 2026 to support the operations of the Medicaid Review Panel. The funding covers operating expenses from July 1, 2025, through June 30, 2026, and includes authority to carry forward any unused funds for nonrecurring expenses in the following fiscal year. The legislation also declares an emergency to allow the appropriation to take effect immediately upon passage, ensuring the panel can continue its work without interruption.
This bill appropriates $30.7 million to the Department of Health and Welfare and $250,000 to the Judicial Branch for fiscal year 2027 to fund assertive community treatment and peer support services. The funding comes from multiple sources, including the State-Directed Opioid Settlement Fund, the Idaho Millennium Income Fund, and federal cooperative welfare funds. The bill also allows the Department of Health and Welfare to transfer money freely between programs to support these services and permits up to $5.8 million of opioid settlement funds to be used for individuals with substance use or mental health issues who do not have opioid use disorder. These changes take effect on July 1, 2026, and the bill was signed into law by the Governor.
S 1313 creates a voluntary licensure pathway for pharmacists in Idaho to become naturopathic doctors by requiring them to complete a 160-credit-hour naturopathic program and pass a competency exam, while maintaining their existing pharmacy license. The bill amends Idaho Code to include pharmacists in the definition of "licensed naturopathic doctor" and updates committee structures to reflect this new option, including adding a pharmacist to the formulary committee. The law will take effect on July 1, 2026.
Idaho's H 648 requires health benefit plans covering FDA-approved anticancer medications to treat oral and injected drugs equally for cost-sharing (like copays and deductibles) starting January 1, 2027. This directly affects health insurance plans sold in Idaho that cover anticancer medications, ensuring patients pay the same out-of-pocket costs regardless of whether their medication is taken orally or administered via injection. The bill does not prevent insurers from using formularies, prior authorization, or other standard coverage controls. It specifically applies to medications approved by the FDA for cancer treatment, with the law taking effect July 1, 2026, for implementation.
This bill requires Idaho-resident students receiving state-funded medical or veterinary education to sign contracts committing to practice in Idaho for specific periods. Medical students must practice full-time in Idaho for four years after obtaining a license, finishing residency, or completing a fellowship. Veterinary students starting in fall 2027 must dedicate at least 600 annual hours to agricultural animal care (cattle, sheep, goats, swine) and complete a mixed practice program. Students who fail to meet these commitments must reimburse the state for their education costs over eight years without interest, with limited exceptions for hardship. A new reimbursement fund will manage these payments and distribute incentive grants to Idaho physicians.
This bill appropriates $35.7 million to Idaho's Department of Health and Welfare for public health services in fiscal year 2027, while reducing the budget for laboratory services by $78,400 and cutting three full-time equivalent positions. The funding covers physical health services, immunization programs, and disease prevention efforts including suicide prevention, HIV surveillance, and hepatitis monitoring. The legislation requires the department to submit annual reports by December 31, 2026, detailing outcomes and return on investment for these programs. The bill also mandates a specific report on vaccine utilization rates and cost savings from the Immunization Assessment Fund.
